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mmunocompromised Travelers
. Jong
University of Washington, Seattle, WA, USA
In the future, increasing numbers of travelers may have
ompromised immune systems due to advanced age, medi-
ations taken for chronic conditions, infection with human
mmunodeﬁciency virus, and immune deﬁcits associated
ith congenital syndromes, systemic diseases, and/or treat-
ents. A complete medical history is necessary during the
re-travel health evaluation. Recommendations for travel
accines, malaria chemoprophylaxis, and care of common
ravel ailments such as traveler’s diarrhea must be tailored
o the individual’s health status.
Required (e.g. yellow fever, meningococcal disease) and
ecommended (e.g. inﬂuenza, hepatitis A and B, typhoid,
abies) travel vaccines may be contraindicated or be less
fﬁcacious in the immunocompromised (IC) traveler. In
ome cases, timing or adjustment of vaccine doses may
ptimize the immune protection elicited. Drugs for preven-
ion of malaria may interact with medications taken on a
egular basis, necessitating additional laboratory testing,
osage changes, and/ or the selection of alternate pre-
ention strategies. Some IC travelers may have increased
usceptibility to gastrointestinal pathogens, and may war-
ant consideration of prophylactic antibiotics as well as
peciﬁc instruction on food safety at destination. The risk of
eographically focal infections such as visceral leishmania-
is, certain fungal infections transmitted through inhalation
Penicillium marneffei in Southeast Asia and coccidiomy-
osis in the Americas) and tuberculosis in some developing
ountries must be considered because of the increased pos-
ibility of severe disease in IC persons.
Travelers with speciﬁc needs, such as the IC traveler,
hould seek travel health advicemonths in advance of depar-
ure, so that the travel health specialist and the primary
are provider have adequate time to communicate about
nd coordinate the medical aspects of the trip preparation.
dentiﬁcation of medical resources at destination, how to
btain special drugs and medical supplies in case of need,
nd emergency medical evacuation are additional important
re-travel topics for these travelers.
oi:10.1016/j.ijid.2010.02.1896
5.004
regnant Travelers
. Carroll
The Pregnant Traveler, Spring Lake, MI, USA
Pregnancy is not an illness, but it is an altered state of
ealth during which many physiologic changes occur. These
hanges need to be considered when advising a pregnant
oman regarding international travel, especially to remote
ocations.
Some examples are changes in renal and metabolic sta-
us that affect pharmacokinetics, cardiorespiratory changes
hat need to be considered in high altitudes, gastrointesti-
al changes that predispose to traveler’s diarrhea, and
w
a
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mmunologic changes that must be considered when giving
mmunizations. These and related matters are discussed in
his presentation on pregnancy and travel. Also discussed
re practical comfort and safety measures for the pregnant
raveler, insurance issues and assistance in ﬁnding medical
are.
While immunization and prophylactic medications are
he topics that raise the most concern among providers,
hese are not the most common problems encountered by
regnant travelers.
Attention to these few basic principles will greatly reduce
he anxiety that patient and provider are both apt to feel
hen travel is combined with pregnancy.
oi:10.1016/j.ijid.2010.02.1897
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roMED and HealthMap: Collaboration to improve emerg-
ng disease surveillance
. Madoff1,∗, J. Brownstein2
ProMED-mail and ISID, Boston, MA, USA
Childrens Hospital, Boston, USA
Unofﬁcial or informal sources (also called ‘‘rumors’’ or
‘unstructured data’’) of emerging disease outbreaks such
s media reports and ﬁrsthand accounts have become an
mportant mechanism for detecting these outbreaks. These
ources are disseminated by a variety of human-based and
utomated biosurveillance networks that are now routinely
onitored by public health authorities at all levels. The 2005
evisions to the International Health Regulations recognize
hat these sources often appear in advance of ofﬁcial notiﬁ-
ation of disease threats and are important in allowing the
imely response to emerging diseases. Early media reports
f respiratory illness in Mexico were among the ﬁrst signs of
he H1N1 pandemic and unofﬁcial information sources are a
ritical mechanism for following the pandemic. ProMED-mail
the Program for Monitoring Emerging Diseases of the Inter-
ational Society for Infectious Diseases) has used largely
umanbased reporting to detect and report outbreaks of
merging infectious diseases since 1994.
HealthMap, based at Boston Children’s Hospital and Har-
ard Medical School, uses automated mining of open sources
n multiple languages to detect emerging disease outbreaks
n and place them on a world map. ProMED and HealthMap
ave begun to collaborate to exploit the strengths of human-
ased and automated detection and reporting systems.
tudies to evaluate the use of informal sources and to
mprove the detection of emerging disease outbreaks are in
rogress and have found differences in timeliness of report-
ng depending on disease type and geographic location.
hese differences are being used to target the development
f new regional and disease speciﬁc reporting networks as
ell as the deployment of new mobile tools for capturing
nd disseminating news of emerging threats.
oi:10.1016/j.ijid.2010.02.1898
